Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$28.51 - $32.9 $6.45 Million - $7.45 Million
-226,345 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$23.54 - $31.39 $425,791 - $567,782
-18,088 Reduced 7.4%
226,345 $6.04 Million
Q2 2021

Aug 13, 2021

SELL
$26.72 - $33.19 $228,616 - $283,973
-8,556 Reduced 3.38%
244,433 $7.53 Million
Q1 2021

May 13, 2021

SELL
$24.15 - $31.45 $303,372 - $395,074
-12,562 Reduced 4.73%
252,989 $6.62 Million
Q4 2020

Feb 10, 2021

BUY
$17.7 - $25.81 $724,779 - $1.06 Million
40,948 Added 18.23%
265,551 $6.68 Million
Q3 2020

Nov 12, 2020

BUY
$20.2 - $25.05 $4.54 Million - $5.63 Million
224,603 New
224,603 $4.68 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.43B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.